Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

GW 7647 (CAS 265129-71-3)

5.0(1)
Write a reviewAsk a question

See product citations (6)

Alternate Names:
2-(4-(2-(1-Cyclohexanebutyl)-3-cyclohexylureido)ethyl)phenylthio)-2-methylpropionic acid; GW7647
Application:
GW 7647 is a potent PPARα agonist with 200-fold selectivity over PPARγ and PPARδ
CAS Number:
265129-71-3
Purity:
>98%
Molecular Weight:
502.8
Molecular Formula:
C29H46N2O3S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

GW 7647 is a potent PPARalpha agonist with 200-fold selectivity over PPARgamma and PPARdelta. This compound has also been found to cause an up-regulation of beta-oxidation gene expression and an increase in palmitate oxidation. Additionally, glycolysis is strongly reduced at transcriptional levels by GW 7647 leading to a decrease in lactate and pyruvate production. Furthermore, this agent displays the ability to decrease glucose oxidation and inhibit lipogenesis and triglyceride esterification.


GW 7647 (CAS 265129-71-3) References

  1. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer.  |  Gupta, RA., et al. 2000. Proc Natl Acad Sci U S A. 97: 13275-80. PMID: 11087869
  2. Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis.  |  Brown, PJ., et al. 2001. Bioorg Med Chem Lett. 11: 1225-7. PMID: 11354382
  3. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors.  |  Cunard, R., et al. 2002. J Immunol. 168: 2795-802. PMID: 11884448
  4. Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy.  |  Rampler, H., et al. 2003. Mol Genet Metab. 80: 398-407. PMID: 14654352
  5. PPARalpha agonists inhibit nitric oxide production by enhancing iNOS degradation in LPS-treated macrophages.  |  Paukkeri, EL., et al. 2007. Br J Pharmacol. 152: 1081-91. PMID: 17891158
  6. Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human white adipocytes.  |  Ribet, C., et al. 2010. Endocrinology. 151: 123-33. PMID: 19887568
  7. Differential regulation of stimulated glucose transport by free fatty acids and PPARα or -Δ agonists in cardiac myocytes.  |  Asrih, M., et al. 2012. Am J Physiol Endocrinol Metab. 302: E872-84. PMID: 22297301
  8. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.  |  Nayeem, MA., et al. 2013. Am J Physiol Regul Integr Comp Physiol. 304: R23-32. PMID: 23152114
  9. Long-term stability of primary rat hepatocytes in micropatterned cocultures.  |  Ukairo, O., et al. 2013. J Biochem Mol Toxicol. 27: 204-12. PMID: 23315828
  10. Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment.  |  Lebeck, J., et al. 2015. Am J Physiol Gastrointest Liver Physiol. 308: G198-205. PMID: 25477377
  11. Ciliogenesis is reciprocally regulated by PPARA and NR1H4/FXR through controlling autophagy in vitro and in vivo.  |  Liu, ZQ., et al. 2018. Autophagy. 14: 1011-1027. PMID: 29771182
  12. Naringenin Promotes Thermogenic Gene Expression in Human White Adipose Tissue.  |  Rebello, CJ., et al. 2019. Obesity (Silver Spring). 27: 103-111. PMID: 30506905
  13. A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities.  |  Peiretti, F., et al. 2020. J Med Chem. 63: 13124-13139. PMID: 33142057

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

GW 7647, 1 mg

sc-203068A
1 mg
$49.00

GW 7647, 5 mg

sc-203068
5 mg
$170.00

GW 7647, 10 mg

sc-203068B
10 mg
$267.00

GW 7647, 25 mg

sc-203068C
25 mg
$661.00